TXNIP and breast cancer: A significant negative correlation was found between TXNIP and Her-2 status using the breast cancer tissue-array (n=150) (r=-0.334, P<0.001), which was again validated in the external cohort (n=101) (r=-0.422, P<0.001) (Table 3).